Skip to main content

The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases. Through its affiliation with the University of Zurich, the editorial mandate of the "European Heart Journal" and as the seat of the "Foundation for Cardiovascular Research", the Zurich Heart House is one of the most important cardiology research and education centres in Europe.

The Zurich Heart House is a place of creative knowledge exchange between researchers, scientists, clinicians, practicing physicians, lecturers and staff. As a think tank, it is intended to strengthen Zurich as a location and serve as a service centre for doctors and patients with cardiovascular diseases.

ZHH News

TFLYouTube

InsideCardiology: New Hot Topics in Cardiology Video!

Check out the new video on "Vascular Dementia: A preventable cause of cognitive decline" with Professor Thomas F. Lüscher.

Watch the video and subscribe to InsideCardiology here!

TFL

InsideCardiology: New Hot Topics in Cardiology Video!

Check out the new video on "Guidelines" with Professor Thomas F. Lüscher.

Watch the video and subscribe to InsideCardiology here!

CardUpLondon2023

Cardiology Update London 2023 | Replay videos are NOW available on demand!

The video recordings of the Cardiology Update London 2023 meeting are now available on demand HERE!

Cardiology News

Cardiac Sarcoidosis

Cardiac Sarcoidosis – An Underrecognized Myocardial Disease

Sarcoidosis is a multisystemic, chronic inflammatory disorder involving lymph nodes and lungs characterized by a non-caseating, epithelioid cell granulomatous inflammation of affected organs. Cardiac involvement has been reported in 5-30% depending on the diagnostic criteria.

Read full article (Cardiovasc Med | 2024;27(1):1–3)

 

Galassi

Evaluation and management of patients with coronary chronic total occlusions considered for revascularisation

Chronic total occlusions (CTOs) of coronary arteries can be found in the context of chronic or acute coronary syndromes; sometimes they are an incidental finding in those apparently healthy individuals undergoing imaging for preoperative risk assessment.

Read full article (EuroIntervention, 2024;20:e174-e184)

Prevention

Screening and prevention in congenital heart disease: Whom, when, and how?

The treatment of congenital heart disease has been one of the triumphs of modern cardiology and cardiac surgery. Most children born with congenital heart disease now survive to adulthood and this has created a new specialty with many challenges.

Read full article (International Journal of Cardiology Congenital Heart Disease 14 (2023) 100480)